Molecular Diagnosis MDx Market Insights Video

According to Cognitive Market Research, the global Molecular Diagnosis MDx market size is USD 32514.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.10% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 13005.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 9754.35 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 7478.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 1625.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 650.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
• Oncology accounts for the majority of the MDx market